Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the average analyst EPS estimate compiled by FactSet of $2.68.

A former PGA Tour player had his own calamity on the par-3 16th at Royal Portrush, calling it the most embarrassing shot of his career.

TIFF’s 50th edition has also set world premieres for Nicholas Hytner’s 'The Choral,' Derek Cianfrance's 'Roofman' and Clement Virgo's psychological thriller 'Steal Away.'

C.J. Gardner-Johnson said he "retracts" the comments he made about the Philadelphia Eagles after he was traded to the Houston Texans this offseason, when he said the team "probably won't see a ring without me.

In March, the Eagles traded Gardner-Johnson and a 2026 sixth-round draft pick to the Texans in exchange for guard Kenyon Green and a 2025 fifth-round draft pick. Last month, Gardner-Johnson said he felt highly disrespected by the trade but understood the business aspect of the decision.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68. The pharmaceutical giant reported sales of $23.

Wis., discusses mortgage fraud accusations against Democratic Sen. Adam Schiff, Senate efforts to codify DOGE spending cuts, and his investigation into former President Biden's pardons.

Johnson shared yet another personal insight that nobody asked for: His jizz has substantially more microplastics in it than his blood does. On X on Tuesday, Johnson posted: “I have microplastics in my ejaculate.

In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its popular immune system medicine Stelara, which is facing a patent cliff. Sales in its smaller, medtech division increased 6 per cent.